A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleA Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsEric J Lawitz